coactiv
inhibitori
receptor
share
least
one
ligand
interact
wide
varieti
ligand
indic
import
rang
situat
discuss
principl
mainli
human
pair
receptor
function
ligand
recognit
possibl
therapeut
implic
target
receptor
cancer
autoimmun
diseas
allergi
summaris
emphasis
idea
receptor
evolv
part
respons
pathogen
pressur
finetun
immun
respons
preserv
homeostasi
pathogen
tumour
use
domin
inhibitori
receptor
coactiv
receptor
avoid
immun
elimin
final
discuss
option
use
pair
receptor
ligand
immun
cell
educ
therapi
current
model
immunolog
activ
expand
knowledg
singl
ligandreceptor
interact
integr
model
sever
receptor
combinatori
role
activ
specif
type
immun
cell
model
cell
activ
clear
exampl
wherea
canon
cell
receptor
tcr
thought
provid
primari
activ
signal
costimulatori
receptor
solubl
factor
becom
integr
part
complex
pictur
similarli
mast
cell
primarili
activ
ige
receptor
fceri
solubl
factor
inhibitori
activ
coactiv
receptor
togeth
modul
activ
mast
cell
complex
immunolog
signal
best
exemplifi
natur
killer
nk
cell
cell
singl
receptor
ultim
respons
cellular
activ
rather
balanc
signal
wide
varieti
activ
receptor
coactiv
receptor
inhibitori
receptor
togeth
solubl
factor
determin
nk
cell
activ
comprehens
understand
integr
signal
process
recent
becom
great
clinic
signific
owe
develop
immun
checkpoint
inhibitor
inhibitori
coactiv
receptor
recognis
cellular
ligandswhich
refer
pair
receptor
broader
definit
previou
one
see
trend
focu
review
figur
see
also
brief
descript
receptor
select
exampl
first
discuss
pair
receptor
defin
may
evolv
describ
complex
express
pattern
determin
control
trend
pair
receptor
initi
describ
activ
inhibitori
receptor
homolog
extracellular
domain
locat
close
proxim
genom
give
broader
definit
pair
receptor
includ
inhibitori
coactiv
receptor
member
least
one
common
cellular
ligand
upon
bind
exert
contrast
effect
inhibit
costimul
pair
inhibitori
receptor
bind
share
ligand
greater
affin
coactiv
receptor
highaffin
bind
inhibitori
receptor
result
also
competit
bind
inhibitori
receptor
also
exert
function
physic
interact
activ
receptor
prevent
activ
inhibitori
receptor
ligand
pair
receptor
use
pathogen
tumour
immun
evas
activ
hypothesis
pair
receptor
probabl
evolv
mainli
respons
pathogen
also
use
maintain
immun
cell
respons
state
suggest
also
limit
overzeal
inflamm
dampen
activ
signal
provid
coactiv
receptor
could
least
case
lead
autoimmun
furthermor
discuss
pathogen
manipul
pair
receptor
infect
cell
subsequ
evad
immun
attack
final
examin
potenti
use
pair
receptor
therapeut
target
variou
clinic
situat
propos
pair
receptor
might
involv
immun
cell
educ
process
immun
cell
acquir
function
capabl
histor
studi
mous
receptor
receptor
famili
nk
cell
also
known
killer
cell
lectinlik
receptor
subfamili
klra
famili
significantli
contribut
concept
pair
receptor
review
due
text
limit
abl
elabor
possibl
aspect
pair
receptor
instead
highlight
sever
exampl
furthermor
although
mani
known
pair
receptor
human
mice
focu
mainli
wellcharacteris
human
pair
enabl
us
best
present
gener
principl
outlin
regard
discuss
pair
receptor
inhibitori
activ
protein
recognis
ligand
well
defin
leukocyt
immunoglobulinlik
receptor
lilr
famili
receptor
one
pair
seem
function
human
pair
immunoglobulinlik
type
receptor
pilra
pair
receptor
initi
describ
activ
inhibitori
receptor
highli
homolog
extracellular
domain
locat
close
proxim
genom
receptor
recognis
cellular
ligand
seem
evolv
togeth
gene
duplic
pair
receptor
belong
mani
differ
famili
molecul
includ
member
immunoglobulin
superfamili
lectin
famili
lectinlik
protein
famili
today
receptor
locat
next
genom
inhibitori
receptor
tigit
cell
immunoreceptor
immunglobulin
itim
domain
coactiv
receptor
dnax
accessori
molecul
also
known
inhibitori
receptor
mark
red
higher
affin
share
ligand
activ
receptor
receptor
pair
exampl
tigit
versu
result
higher
affin
ligand
inhibitori
receptor
compet
activ
partner
ligand
bind
inhibitori
receptor
physic
interrupt
bind
activ
receptor
ligand
also
evid
inhibitori
receptor
interfer
homodimer
correspond
activ
receptor
therebi
prevent
signal
activ
receptor
eg
tigit
interfer
homodimeris
abbrevi
dnax
accessori
molecul
tigit
cell
immunoreceptor
immunglobulin
itim
domain
inhibitori
receptor
also
known
pvrig
also
consid
pair
receptor
recognis
cellular
ligand
mainli
polioviru
receptor
pvr
oppos
effect
inhibit
coactiv
purpos
articl
therefor
defin
pair
receptor
pair
receptor
includ
inhibitori
coactiv
receptor
member
pair
least
one
common
cellular
ligand
tabl
upon
bind
ligand
member
pair
exert
contrast
effect
inhibit
costimul
figur
note
pair
receptor
context
articl
need
function
link
signal
independ
otherin
word
inhibitori
receptor
need
directli
inhibit
signal
activ
receptor
nk
cell
express
numer
activ
inhibitori
receptor
singl
domin
activ
receptor
thu
function
mainli
balanc
effector
inde
express
widest
varieti
pair
receptor
tabl
interestingli
pair
receptor
identifi
far
includ
independ
function
bona
fide
activ
receptor
function
independ
nk
cell
natur
cytotox
receptor
ncr
activ
nk
cell
fceri
mast
cell
instead
coactiv
receptor
function
independ
pair
inhibitori
receptor
pair
receptor
inhibitori
receptor
seem
bind
share
ligand
greater
affin
coactiv
receptor
determin
vitro
assay
tabl
although
vitro
affin
may
accur
reflect
cell
membran
environ
vivo
observ
suggest
healthi
steadyst
condit
inhibitori
receptor
coactiv
receptor
express
cell
bind
share
ligand
domin
signal
like
inhibit
highaffin
bind
inhibitori
receptor
also
result
competit
bind
wherebi
inhibitori
receptor
physic
interrupt
bind
coactiv
receptor
ligand
figur
addit
inhibitori
receptor
also
exert
function
receptorextrins
manner
exampl
inhibitori
receptor
tigit
shown
disrupt
homodimeris
bind
partner
thu
interf
coactiv
receptor
function
figur
activ
coactiv
receptor
signal
mainli
immunoreceptor
tyrosinebas
activ
motif
itam
wherea
inhibitori
receptor
signal
immunoreceptor
tyrosinebas
inhibitori
motif
itim
sever
coactiv
pair
receptor
itim
sequenc
untransl
region
suggest
may
evolv
inhibitori
receptor
inde
inhibitori
receptor
often
use
pathogen
immun
evas
discuss
immun
cell
seem
acquir
coactiv
receptor
later
evolut
inhibitori
receptor
counterattack
pathogen
model
well
repres
pair
receptor
express
nk
cell
inhibitori
receptor
recognis
host
mhc
class
molecul
downregul
surfac
virusinfect
cell
lead
nk
cell
activ
mous
cytomegaloviru
mcmv
therefor
evad
immun
respons
produc
viral
mhc
class
ilik
ligand
inhibitori
howev
mcmvresist
mous
strain
also
express
activ
receptor
recognis
directli
kill
mcmvinfect
cell
still
even
case
seem
inhibitori
interact
domin
bind
constant
determin
adam
et
al
use
surfac
plasmon
reson
spr
k
nm
interact
k
mm
interact
activ
inhibitori
receptor
pair
interact
ligand
inhibit
domin
coactiv
receptor
pair
effect
pair
receptor
tigit
nk
cell
express
constitut
cell
howev
immun
cell
express
coactiv
receptor
pair
exampl
mast
cell
eosinophil
express
coactiv
receptor
inhibitori
receptor
counterpart
tigit
interestingli
effector
cell
allergi
also
express
nectin
ligand
tigit
express
mast
cell
eosinophil
coactiv
receptor
ligand
mean
cell
come
togeth
enhanc
activ
explain
selffuel
proinflammatori
allerg
effector
unit
aeu
thu
tissueresid
mast
cell
start
allerg
respons
eosinophil
penetr
tissu
interact
via
solubl
mediat
physic
bind
mast
cell
form
aeu
synergist
overactiv
mast
cell
eosinophil
exampl
patholog
lie
wait
pair
receptor
becom
unbalanc
certain
situat
pair
receptor
express
type
immun
cell
necessarili
clone
enabl
clonaldepend
activ
coactiv
receptor
human
killer
cell
immunoglobulinlik
receptor
kir
short
long
cytoplasm
domain
long
form
inhibitori
short
form
activ
coactiv
stochast
express
nk
cell
kir
haplotyp
activ
receptor
thu
may
function
independ
certain
nk
cell
clone
similarli
case
bind
phosphatidylserin
phosphatidylethanolamin
oppos
effect
nk
cell
express
member
receptor
pair
stochast
case
pair
receptor
express
cell
spatial
express
receptor
may
determin
abil
function
exampl
differenti
express
pair
receptor
differ
zone
nk
cell
inhibitori
activ
synaps
influenc
activ
concept
immun
synaps
import
remind
cell
exist
three
dimens
locat
crucial
thu
even
inhibitori
coactiv
pair
receptor
present
cell
might
segreg
differ
cellular
domain
follow
gather
intercellular
contact
immun
synaps
domain
sometim
associ
differ
signal
molecul
situat
coactiv
receptor
might
function
level
express
number
densiti
inhibitori
coactiv
member
pair
receptor
might
also
affect
activ
inde
although
inhibitori
receptor
overal
higher
affin
ligand
may
present
lower
densiti
cell
surfac
coactiv
counterpart
therefor
context
target
cell
express
low
level
common
ligand
inhibitori
receptor
engag
ligand
first
thu
prevent
engag
activ
counterpart
lead
domin
inhibit
contrast
context
target
cell
express
high
level
ligand
activ
receptor
also
engag
owe
greater
densiti
cell
surfac
respond
cell
compar
inhibitori
receptor
domin
respons
activ
final
pair
receptor
express
cell
differ
time
point
wellcharacteris
exampl
cytotox
lymphocyt
antigen
ctla
bind
activ
immatur
cell
well
control
rigor
educ
process
thymu
later
stage
cell
activ
peripheri
must
check
well
achiev
pair
receptor
coactiv
receptor
express
cell
allow
respond
signal
present
dendrit
cell
dc
sens
pathogen
cell
howev
yet
express
inhibitori
receptor
express
convent
cell
occur
tcr
activ
express
inhibit
cell
activ
variou
mechan
includ
direct
signal
compet
ligand
even
grab
degrad
ligand
target
cell
result
higher
affin
inhibitori
receptor
ligand
pair
receptor
seem
provid
balanc
form
inhibit
homeostat
condit
inact
favour
group
receptor
therebi
larg
part
immun
system
whole
enabl
nk
cell
harbour
cytolyt
granulesand
mast
cell
contain
granul
proinflammatori
mediatorsnot
harm
normal
tissu
still
respond
quickli
alreadi
present
coactiv
receptor
danger
simultan
presenc
inhibitori
coactiv
receptor
also
keep
immun
cell
respons
state
allow
detect
small
variat
within
environ
exampl
nk
cell
absenc
mhc
class
hyporespons
indic
inhibitori
receptor
signal
might
involv
educ
respons
nk
cell
also
propos
chronic
activ
receptor
signal
deliv
absenc
inhibit
desensit
nk
cell
lead
hyporespons
process
refer
disarm
thu
pair
coactiv
inhibitori
receptor
might
coexist
fine
tune
respons
immun
cell
environ
ensur
homeostat
condit
cell
remain
quiescent
still
function
upon
subtl
rapid
chang
environ
eg
increas
ligand
densiti
provid
addit
ligand
activ
receptor
cell
abl
respond
effici
theori
directli
relat
discontinu
theori
postul
vivier
colleagu
propos
immun
cell
gener
effector
respons
discontinu
sudden
chang
antigen
stimul
wherea
tend
becom
toler
continu
slow
continu
stimul
varieti
share
ligand
pair
receptor
impress
pair
receptor
recognis
everyth
protein
sugar
lipid
nucleic
acid
tabl
vast
divers
potenti
ligand
indic
might
involv
larg
number
immun
respons
clinic
situat
mani
remain
discov
mani
share
ligand
ubiquit
express
normal
condit
tabl
may
repres
role
pair
receptor
basic
method
immun
homeostasi
healthi
tissu
constantli
beingsens
thepair
receptorsso
immun
respons
aredampen
pathogen
also
sens
pair
receptor
exampl
carcinoembryon
antigenrel
cell
adhes
molecul
short
long
isoform
recognis
particularli
larg
set
pathogen
ligand
differ
virus
bacteria
tabl
mani
case
viru
recognit
pair
receptor
benefici
viru
exampl
facilit
infect
sever
mosquitoborn
virus
includ
dengu
west
nile
chikungunya
virus
addit
protein
human
herpesviru
mimic
downregul
macrophag
activ
receptor
interestingli
coactiv
receptor
mainli
describ
mice
show
substanti
bind
express
cellular
ligand
pair
receptor
also
modul
pathogen
exampl
cell
surfac
express
bind
homophil
pair
receptor
express
effector
cell
upregul
infect
target
cell
follow
infect
sever
virus
cellular
transform
also
lead
upregul
ligand
pair
receptor
exampl
express
pvr
tigit
ligand
upregul
mani
solid
tumour
final
ligand
phosphatidylserin
phosphatidylethanolamin
normal
express
cell
surfac
follow
apoptosi
recognis
upregul
even
absenc
apoptosi
follow
viral
infect
malign
transform
allerg
inflamm
underli
mechan
well
understood
discuss
inhibit
domin
respons
pair
receptor
pathogen
tumour
benefit
upregul
cellular
ligand
pair
receptor
protect
immun
cell
attack
wide
varieti
pathogen
use
share
ligand
pair
receptor
cellular
adhes
entri
receptor
see
tabl
viru
exampl
particular
sialic
acid
use
wide
adhes
andor
entri
receptor
virus
possibl
ubiquit
express
sialic
acid
make
attract
target
virus
adher
thereaft
invad
mani
type
cell
pair
receptor
ligand
use
entri
receptor
virus
wide
express
classic
exampl
pvr
discov
role
entri
receptor
polioviru
year
later
shown
pvr
bind
pair
receptor
tigit
pvr
also
ligand
although
unclear
whether
receptor
inhibitori
activ
function
bacteria
also
use
pair
receptor
ligand
entri
receptor
exampl
helicobact
pylori
bind
use
hopq
protein
facilit
transloc
virul
protein
caga
host
cell
particular
clinic
import
caga
implic
promot
gastric
cancer
patholog
altogeth
given
know
function
pair
receptor
immun
system
great
deal
evolutionari
sens
behind
use
share
ligand
entri
receptor
especi
sinc
seem
inhibitori
receptor
pair
receptor
develop
prior
develop
activ
one
figur
express
share
ligand
may
shield
invad
pathogen
earli
stage
cellular
infect
gener
vulner
elimin
immun
cell
addit
baselin
immuneinhibitori
properti
cell
express
share
ligand
also
mean
lag
period
cell
tip
toward
immuneactiv
state
figur
would
allow
pathogen
prolifer
reach
higher
number
thu
increas
chanc
surviv
immun
attack
start
figur
use
share
ligand
entri
receptor
ensur
benefit
provid
pathogen
distinct
advantag
outperform
immun
pressur
howev
pathogen
use
ligand
pair
receptor
entri
receptor
might
view
riski
ligand
also
recognis
coactiv
receptor
thu
hypothesis
pathogen
target
inhibitori
receptor
pair
inhibit
escap
immun
recognit
inde
mention
virus
bacteria
directli
target
pair
receptor
invad
host
cell
send
inhibitori
signal
immun
cell
allow
pathogen
time
replic
safe
ba
host
cell
send
net
signal
immun
system
initi
patholog
process
true
sever
cell
type
beta
cell
pancrea
well
cell
immun
privileg
site
throughout
bodi
time
host
cell
take
produc
signal
suffici
activ
immun
cell
term
bb
host
cell
send
inhibitori
signal
immun
system
baselin
express
share
ligand
process
induc
immuneactiv
signal
take
longer
cross
threshold
requir
activ
immun
system
b
lag
period
b
allow
greater
viral
replic
increas
patholog
develop
immun
intervent
blue
portion
graph
turn
larger
viral
popul
like
surviv
immun
attack
onset
immunopatholog
indic
red
portion
graph
exampl
bacteri
pathogen
target
pair
receptor
fusobacterium
nucleatum
use
protein
bind
tigit
coactiv
partner
inhibit
immun
cell
activ
given
virus
use
ligand
pair
receptor
entri
protein
tumour
upregul
express
pair
receptor
ligand
inhibit
immun
cell
activ
possibl
virus
use
tumour
therapeut
purpos
specif
type
cancer
overexpress
share
ligandfor
exampl
pvr
pancreat
cancer
viru
use
share
ligand
entri
receptor
lyse
cell
could
use
therapeut
case
pancreat
cancer
polioviru
strain
engin
oncolyt
could
prove
use
combat
otherwis
lethal
diseas
idea
particularli
attract
given
fact
patient
pancreat
cancer
higher
express
level
pvr
would
therefor
potenti
respons
oncolyt
viral
therapi
current
poorer
prognos
use
strategi
immun
evas
critic
cancer
cell
surviv
may
turn
target
weak
spot
antibodi
checkpoint
receptor
keytruda
current
success
use
treatment
variou
tumour
similarli
use
array
agonist
antagonist
bispecif
antibodi
pair
receptor
difficult
obtain
due
high
resembl
extracellular
portion
possibl
tip
balanc
immun
respons
direct
agon
coactiv
receptor
antagon
inhibitori
receptor
pair
receptor
could
encourag
immun
system
fight
pathogen
cancer
convers
respons
could
use
treat
rang
autoimmun
disord
allergi
phase
trial
alreadi
underway
examin
use
tigitblock
antibodi
treatment
solid
tumour
bispecif
antibodi
could
use
help
home
correct
cell
type
avoid
side
effect
associ
biolog
therapi
exampl
previous
gener
bispecif
antibodi
target
cc
chemokin
receptor
preferenti
recognis
receptor
mous
eosinophil
inhibitori
pair
receptor
antibodi
use
mous
model
asthma
show
efficaci
reduc
eosinophilia
lung
inflamm
similarli
develop
bispecif
antibodi
target
ige
mast
cell
given
extens
involv
pair
receptor
differ
process
similar
antibodybas
strategi
could
test
variou
diseas
mhc
molecul
involv
educ
process
cell
nk
cell
mhc
molecul
import
regul
strength
cell
reactiv
strong
weak
signal
lead
delet
cell
clone
cours
educ
process
pair
receptor
also
balanc
immun
cell
might
educ
via
interact
share
receptor
share
ligand
recent
shown
nk
cell
review
examin
pair
receptor
sever
perspect
curiou
phenomenon
two
receptor
share
ligand
opposit
effect
immun
cell
except
farreach
consequ
describ
essenti
form
care
balanc
inhibit
inhibit
domin
propos
pair
receptor
sometim
truli
pair
separ
tempor
andor
clonal
sometim
uncoupl
even
express
cell
immunolog
synaps
enabl
costimul
partner
pair
activ
situat
addit
pair
receptor
pair
ligand
exist
mechan
control
express
pair
ligand
better
understand
regul
pair
ligand
express
also
critic
understand
biolog
pair
receptor
pair
receptor
involv
educ
addit
immun
cell
subset
nk
cell
exampl
mast
cell
eosinophil
pathogen
affect
express
pair
receptor
enhanc
express
inhibitori
partner
escap
immun
attack
express
pair
receptor
ligand
manipul
therapi
cancer
pathogen
pair
receptor
found
function
pathogen
nonimmun
cell
purpos
biochem
divers
share
ligand
pair
receptor
less
fascin
ligand
upregul
variou
patholog
use
pathogen
infect
cell
hypothesis
use
share
ligand
entri
adhes
receptor
benefici
pathogen
better
protect
immun
attack
inhibit
domin
respons
suggest
use
properti
gener
oncolyt
virus
could
use
treat
tumour
upregul
share
ligand
furthermor
hypothesis
pathogen
target
inhibitori
receptor
pair
inhibit
escap
immun
recognit
also
propos
pair
receptor
might
involv
educ
variou
immun
cell
look
pair
receptor
whole
understand
intricaci
system
health
diseas
may
prove
use
clinic
applic
receptor
alreadi
link
mani
immunolog
process
mani
role
await
discoveri
see
outstand
question
immunotherapi
undergon
great
improv
past
year
hope
understand
function
pair
receptor
continu
contribut
success
